Back
Viatris 10K Form
Buy
52
VTRS
Viatris
Last Price:
10.8000
Seasonality Move:
14.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-10 | 10Q | VTRS/Viatris Quarterly |
| 2021-03-01 | 10K | VTRS/Viatris Annual |
| 2020-11-10 | 10Q | VTRS/Viatris Quarterly |
| 2020-08-12 | 10Q | VTRS/Viatris Quarterly |
| 2020-05-12 | 10Q | VTRS/Viatris Quarterly |
| 2020-05-07 | 10K | VTRS/Viatris Annual |
Receive VTRS News And Ratings
See the #1 stock for the next 7 days that we like better than VTRS
VTRS Financial Statistics
Sales & Book Value
| Annual Sales: | $16.26B |
|---|---|
| Cash Flow: | $425.9M |
| Price / Cash Flow: | 6.4 |
| Annual Sales: | $17.38 |
| Price / Book: | 0.62 |
Profitability
| EPS (TTM): | 1.53000 |
|---|---|
| Net Income (TTM): | $1.85B |
| Gross Margin: | $6.5B |
| Return on Equity: | 9.1% |
| Return on Assets: | 3.74% |
Viatris Earnings Forecast
Key Viatris Financial Ratios
- The Gross Profit Margin over the past 39 years for VTRS is 39.95%.
- The Selling, General & Administrative Expenses for VTRS have been equal to 25.70% of Gross Profit Margin.
- The Research & Development expenses have been 4.07% of Revenue.
- The Interest Expense is 28.50% of Operating Income.
- The Net Earning history of VTRS is 12.78% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 25 years.
Viatris Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Current Symbol: | VTRS |
| CUSIP: | 92556V |
| Website: | viatris.com |
Debt
| Debt-to-Equity Ratio: | 0.89 |
|---|---|
| Current Ratio: | 1.5 |
| Quick Ratio: | 0.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 6.31 |
|---|---|
| Forward P/E Ratio: | 3.76 |